Everest Organics Ltd
Everest Organics Ltd (EVERESTO) last reported results for the quarter ended Jun 2026, with sales of ₹48.43 crore and net profit of ₹1.11 crore. The stock last traded at ₹248, a market capitalisation of ₹247 crore, on a P/E of 47.0. Over the past 52 weeks the stock has ranged between ₹197 and ₹536. Figures are as of 6 Oct 2026 and are not real time.
Everest Organics Ltd share price and key metrics
- Current price
- ₹248
- Market cap
- ₹247 cr
- Stock P/E
- 47.0
- Book value
- ₹77.7
- ROE
- 7.63%
- ROCE
- 12.0%
- Dividend yield
- 0.00%
- 52w high / low
- 536/197
Metrics as of 6 Oct 2026. Not real time.
Track Everest Organics Ltd
Cruxal reads every Everest Organics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Everest Organics Ltd growth and returns
- 10 Years
- 7%
- 5 Years
- 2%
- 3 Years
- 2%
- TTM
- 5%
- 10 Years
- 21%
- 5 Years
- -17%
- 3 Years
- 315%
- TTM
- -15%
- 10 Years
- 15%
- 5 Years
- -5%
- 3 Years
- 26%
- 1 Year
- -39%
- 10 Years
- 10%
- 5 Years
- 2%
- 3 Years
- 2%
- Last Year
- 8%
Everest Organics Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹48.43 cr, down 10.0% from ₹53.81 cr a year earlier. Net profit was ₹1.11 cr, down 21.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 44.05 | 42.05 | 40.93 | 53.81 | 51 | 42.59 | 48.75 | 48.43 |
| Expenses | 40.62 | 38.03 | 37.49 | 49.37 | 45.87 | 39.05 | 42.05 | 44.1 |
| Operating profit | 3.43 | 4.02 | 3.44 | 4.44 | 5.13 | 3.54 | 6.7 | 4.33 |
| OPM % | 7.79% | 9.56% | 8.40% | 8.25% | 10.06% | 8.31% | 13.74% | 8.94% |
| Other income | 0.14 | 0 | 0.22 | 0.55 | 0.29 | 0.25 | 0.16 | 0.42 |
| Interest | 1.35 | 1.4 | 1.15 | 1.31 | 1.23 | 1.23 | 2.76 | 1.63 |
| Depreciation | 1.47 | 1.47 | 1.56 | 1.52 | 1.52 | 1.52 | 1.93 | 1.59 |
| Profit before tax | 0.75 | 1.15 | 0.95 | 2.16 | 2.67 | 1.04 | 2.17 | 1.53 |
| Tax % | 1.33% | 0.87% | -206.32% | 35.19% | 56.93% | 65.38% | -21.20% | 26.80% |
| Net profit | 0.74 | 1.14 | 2.91 | 1.41 | 1.16 | 0.36 | 2.63 | 1.11 |
| EPS (₹) | 0.92 | 1.42 | 3.00 | 1.45 | 1.19 | 0.37 | 2.71 | 1.14 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Everest Organics Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 107 | 112 | 156 | 167 | 182 | 200 | 183 | 197 | 159 | 196 | 191 |
| Operating profit | 6 | 7 | 18 | 19 | 23 | 6 | 1 | 11 | 7 | 20 | 20 |
| OPM % | 6% | 6% | 11% | 11% | 13% | 3.2% | 0.5% | 6% | 4.5% | 10% | 10% |
| Net profit | 1 | 2 | 8 | 11 | 14 | 1 | -0 | 0 | -1 | 6 | 5 |
| EPS (₹) | 1.69 | 2.14 | 9.39 | 13.62 | 17.15 | 1.42 | -0.22 | 0.18 | -1.33 | 5.72 | 5.41 |
TTM is the trailing twelve months to the most recent quarter.
Everest Organics Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 10 | 10 |
| Reserves | 8 | 11 | 18 | 26 | 39 | 39 | 38 | 38 | 60 | 66 |
| Borrowings | 19 | 22 | 21 | 18 | 23 | 39 | 51 | 58 | 48 | 50 |
| Other liabilities | 51 | 54 | 60 | 68 | 66 | 92 | 105 | 123 | 106 | 114 |
| Total liabilities | 86 | 94 | 107 | 120 | 135 | 178 | 202 | 227 | 223 | 240 |
| Fixed assets | 33 | 34 | 38 | 39 | 44 | 49 | 54 | 52 | 50 | 46 |
| CWIP | 1 | 1 | 0 | 1 | 0 | 8 | 12 | 21 | 23 | 22 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 52 | 60 | 68 | 80 | 92 | 121 | 136 | 153 | 150 | 171 |
| Total assets | 86 | 94 | 107 | 120 | 135 | 178 | 202 | 227 | 223 | 240 |
As reported by the company. Total assets equal total liabilities by construction.
Everest Organics Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 10 | 5 | 9 | 10 | 14 | 14 | 18 | 16 | -5 | 4 |
| Cash from investing | -8 | -4 | -5 | -6 | -12 | -17 | -16 | -13 | -5 | -2 |
| Cash from financing | -2 | -1 | -3 | -3 | -2 | 2 | -3 | -3 | 16 | -8 |
| Net cash flow | 0 | -0 | 1 | 0 | -0 | -1 | 0 | 0 | 6 | -6 |
| Free cash flow | 2 | 1 | 2 | 3 | 7 | -3 | 5 | 3 | -11 | 2 |
| CFO / operating profit | 162% | 64% | 50% | 51% | 59% | 214% | 1,981% | 149% | -76% | 21% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Everest Organics Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 13% | 13% | 35% | 35% | 34% | 6% | 4% | 6% | 2% | 12% |
| Debtor days | 105 | 124 | 95 | 97 | 102 | 125 | 152 | 185 | 202 | 216 |
| Inventory days | 73 | 72 | 71 | 102 | 110 | 110 | 139 | 128 | 166 | 132 |
| Days payable | 260 | 251 | 190 | 211 | 183 | 212 | 282 | 324 | 315 | 262 |
| Cash conversion cycle | -83 | -55 | -24 | -12 | 29 | 24 | 9 | -11 | 53 | 86 |
| Working capital days | -50 | -34 | -15 | 7 | 21 | 9 | -12 | -20 | 3 | 27 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Everest Organics Ltd shareholding pattern
Promoters held 59.60% at Jun 2026, down from 60.99% at Jun 2025. DIIs 0.02%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.15% | 74.15% | 61.09% | 60.99% | 59.64% | 59.61% | 59.58% | 59.60% |
| DIIs | 0.05% | 0.05% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public | 25.81% | 25.80% | 38.90% | 38.99% | 40.35% | 40.36% | 40.40% | 40.38% |
| No. of shareholders | 9,996 | 9,326 | 8,756 | 8,281 | 8,079 | 7,804 | 7,880 | 7,827 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Everest Organics Ltd corporate filings
- Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended September 30, 2026 is enclosed.Company Updatelow impact
- Company: Everest Organics Limited - AGM Results Confirm Reaffirmation of Financials and Board AppointmentsAGM/EGMmedium impact
Cruxal's analysis: Everest Organics Limited held its 33rd AGM on September 30, 2026, via VC/OAVM, with all…
Read the full analysis - Everest Organics Limited holds 33rd AGM; no immediate financial disclosures or strategic updates providedAGM/EGMlow impact
Cruxal's analysis: Everest Organics Limited conducted its 33rd Annual General Meeting on September 30, 2026…
Read the full analysis - Intimation of closure of trading window.Insider Trading / SASTlow impact
- Everest Organics Limited Announces 33rd Annual General Meeting for September 30, 2026Company Updatelow impact
Cruxal's analysis: Everest Organics Limited has issued a formal intimation regarding its 33rd Annual General…
Read the full analysis - Everest Organics Ltd files 33rd Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Everest Organics Ltd has submitted its 33rd Annual Report for the financial year 2025-26…
Read the full analysis - Everest Organics Limited Reports Financial Turnaround for FY 2025-26 with Net Profit of 5.55 croreAGM/EGMhigh impact
Cruxal's analysis: Everest Organics Limited has reported a significant financial turnaround for FY 2025-26…
Read the full analysis - Everest Organics Limited publishes unaudited standalone financial results for the quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Everest Organics Limited has formally published its unaudited standalone financial…
Read the full analysis - Everest Organics Ltd sets cut-off date for 33rd Annual General MeetingCorp. Actionlow impact
Cruxal's analysis: Everest Organics Ltd has announced the cut-off date for determining the eligibility of…
Read the full analysis - Everest Organics Ltd schedules 33rd Annual General MeetingCorp. Actionlow impact
Cruxal's analysis: Everest Organics Ltd has fixed the book closure dates for its 33rd Annual General…
Read the full analysis - Everest Organics Limited strengthens board with strategic appointments of industry veteransBoard Meetingmedium impact
Cruxal's analysis: Everest Organics Limited has announced the appointment of Mr. Srikanth Reddy Kolli and…
Read the full analysis - Everest Organics Limited Reports Q1 FY27 Financial Results Amidst Ongoing Regulatory Qualification Regarding Production CapacityResulthigh impact
Cruxal's analysis: Everest Organics Limited reported Q1 FY27 revenue of 48.43 crore, a decline from 53.81…
Read the full analysis - Everest Organics Limited schedules Board Meeting for August 14, 2026, to approve Q1 FY2026-27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Everest Organics Limited has issued a formal intimation regarding a Board Meeting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.